Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328
Q2 FY25 results · Jul–Sep 2024
Krsnaa Diagnostics reported revenue from operations of ₹186.34 crore (up 19.9% from Q2 FY24) and net profit of ₹19.60 crore (up 86.7% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 186.34 | 155.45 | +19.9% | 170.23 | +9.5% |
| Other income | 4.59 | 4.16 | +10.5% | 7.32 | −37.2% |
| Total income | 190.93 | 159.61 | +19.6% | 177.55 | +7.5% |
| Profit before tax | 25.40 | 13.42 | +89.3% | 23.20 | +9.5% |
| Net profit for the period | 19.60 | 10.50 | +86.7% | 17.92 | +9.3% |
| EPS, basic (₹) | 6.07 | 3.35 | +81.2% | 5.55 | +9.4% |
| Net margin (%) | 10.5 | 6.8 | 10.5 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 178.72 | 146.85 | +21.7% | 163.16 | +9.5% |
| Other income | 4.60 | 4.16 | +10.7% | 7.32 | −37.1% |
| Total income | 183.33 | 151.01 | +21.4% | 170.48 | +7.5% |
| Profit before tax | 28.50 | 14.18 | +100.9% | 23.53 | +21.1% |
| Net profit for the period | 21.96 | 11.31 | +94.2% | 18.18 | +20.8% |
| EPS, basic (₹) | 6.80 | 3.60 | +88.9% | 5.63 | +20.8% |
| Net margin (%) | 12.3 | 7.7 | 11.1 |
Consolidated
- Filed with BSE
- 08 Nov 2024, 15:38 IST
- Board meeting
- 25 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Nov 2024, 15:38 IST
- Board meeting
- 25 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE